Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
An AI-driven solution utilizing X-Ray and CT scans is designed for public health screening, focusing on identifying chest pathologies such as Tuberculosis and COVID-19-related infections. This innovative system, known as Genki, integrates "AI+Expert in the loop" to deliver a comprehensive imaging workflow, where artificial intelligence enhances the capabilities of imaging specialists, resulting in quicker report generation and increased productivity. Utilizing cutting-edge technology, Genki effectively augments X-ray imaging for the analysis of infectious diseases like TB and COVID-19, offering rapid prescreening and triage capabilities. We have meticulously refined the entire workflow to facilitate a seamless process for imaging assessment, diagnosis, and reporting, while a smart notification system alleviates the stress often associated with reporting tasks. Key features of Genki include the ability to classify, localize, and quantify lesions effectively. The solution emphasizes point-of-care diagnostics, which is essential for addressing the gaps in disease elimination, and can be integrated into mobile X-ray units and CT scanners, ensuring immediate triage and prescreening when needed. This approach not only enhances efficiency but also significantly contributes to improving public health outcomes.
Description
AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
DEEPTEK
Country
India
Website
www.deeptek.ai/genki
Vendor Details
Company Name
Lunit
Country
United States
Website
www.lunit.io/en